Delivery Order SPE2DB22D1106-SPE2DB24FEVK9

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp. is a Delivery Order valued at $11,683.86 for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is a delivery order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S, with a ceiling value of $3,275.74. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency supporting the Department of Defense. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $27,156.55 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60s, a prescription medication, with a performance period through April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.50 firm fixed-price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trelegy Ellipta pharmaceutical products, valued at $2,680.83. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. This is a delivery order contract with a firm-fixed price pricing type. The contract has a completion date of June 18, 2024 and was...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trelegy Ellipta 200-62.5-25 60S pharmaceutical product to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $4,327.89, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The $11,144.01 award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Trelegy Ellipta 100-62.5-25 28S. The $2,255.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,353.63 firm fixed price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,458.73 firm fixed-price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. The contract has a completion date of June 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEVK9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,251.29 for the supply of the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is issued under this larger IDC contract. There is no set-aside designation for this order.

Generated 9/4/24, 9:10 AM